DexCom Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
29,800.00
22,400.00
57,600.00
65,600.00
50,200.00
127,100
Depreciation, Depletion & Amortization
7,000.00
8,400.00
10,800.00
15,000.00
16,100.00
29,100
Other Funds
28,000.00
50,400.00
120,200.00
113,100.00
123,500.00
262,100
Funds from Operations
5,200.00
36,400.00
73,400.00
62,500.00
89,400.00
164,100
Changes in Working Capital
2,800.00
12,800.00
25,400.00
6,300.00
2,600.00
40,900
Net Operating Cash Flow
2,400.00
23,600.00
48,000.00
56,200.00
92,000.00
123,200
Capital Expenditures
7,900.00
16,200.00
33,300.00
55,700.00
66,000.00
Sale of Fixed Assets & Businesses
-
-
-
300.00
-
Purchase/Sale of Investments
28,800.00
600.00
17,700.00
500.00
78,400.00
Net Investing Cash Flow
20,900.00
16,800.00
51,500.00
55,900.00
144,400.00
Issuance/Reduction of Debt, Net
200.00
2,200.00
2,300.00
2,300.00
389,000.00
Net Financing Cash Flow
11,800.00
21,800.00
16,800.00
8,100.00
399,100.00
Net Change in Cash
35,100.00
28,600.00
13,300.00
8,400.00
347,000.00
Free Cash Flow
5,500.00
7,400.00
14,700.00
500.00
26,000.00
Net Assets from Acquisitions
-
-
500.00
-
-
Change in Capital Stock
12,000.00
24,000.00
19,100.00
10,400.00
10,100.00
Miscellaneous Funds
-
-
-
-
300.00

About DexCom

View Profile
Address
6340 Sequence Drive
San Diego California 92121
United States
Employees -
Website http://www.dexcom.com
Updated 07/08/2019
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F.